Autres langues Alpha MOS

Actions

ALNEO

FR0013421286

Temps réel Euronext Paris Autres places de cotation 12:14:35 16/04/2024			Varia. 5j.	Varia. 1 janv.
0,53 ^EUR	-10,17 %		-7,02 %	-36,45 %

10/04	Alpha MOS : le concert dépasse les 90% des votes	CF
05/04	Alpha MOS : levée de fonds bouclée pour la filiale 'medtech'	CF

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Alpha MOS : le concert dépasse les 90% des votes	10/04
Alpha MOS : levée de fonds bouclée pour la filiale 'medtech'	05/04
Alpha Mos : BOYDSense completes a EUR 7m capital increase to further develop its non-invasive glucose monitoring device	05/04
Alpha MOS : le titre dévisse après l'augmentation de capital	08/03
Alpha MOS S.A. announced that it expects to receive ?6.29236 million in funding	07/03
Alpha MOS : le titre dévisse après un avertissement	18/12
Alpha Mos : INTERIM RESULTS AT 30 JUNE 2023	30/10/23
Alpha MOS S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	30/10/23
EU Clears Marketing Authorization for Marinus Pharmaceuticals' Ztalmy	31/07/23
Alpha Mos : Conclusion of the 2nd BOYDSense clinical study	01/06/23
Alpha MOS : Conclusion of the 2nd BOYDSense clinical study	01/06/23
Alpha Mos : Mengniu, a Chinese leader of dairy products validates Alpha MOS electronic noses performance for milk control	11/05/23
Alpha MOS S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
Alpha MOS : BOYDSense (an Alpha MOS subsidiary), selected among the 12 most innovative French Medtech by the National Union of the Medical Technology Industry (SNITEM)	07/02/23
Alpha MOS : BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury	12/12/22
Alpha MOS S.A. announced that it has received €3 million in funding from NextStage AM	09/12/22
Alpha MOS S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	28/10/22
Alpha MOS : Development acceleration booster for BOYDSense’s breath analyser platform for people living with Diabetes thanks to the support of the European Innovation Council (EIC)	30/08/22
Alpha MOS SA Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22
Alpha MOS : Ben Delhey appointed as CEO of BOYDSense, the MedTech subsidiary of Alpha MOS	03/02/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Alpha MOS

Actions

ALNEO

FR0013421286

Autres langues

Filtres